Statera BioPharma, Inc.: Statera Biopharma Files Form 10-Q and Reaches Agreement with Silverback Capital and AVOF
FORT COLLINS, CO / ACCESSWIRE / October 21, 2022 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that
United States Russian Federation Statera Biopharma Michael Handley Cleveland Biolabs Statera Biopharma Inc View
Source: finanznachrichten.de